Federal Reserve Economic Data: Your trusted data source since 1991

Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter (QFR120385USNO)

Observation:

Q1 2024: 13,126 (+ more)   Updated: Jun 10, 2024 9:07 AM CDT
Q1 2024:  13,126  
Q4 2023:  20,230  
Q3 2023:  11,790  
Q2 2023:  17,511  
Q1 2023:  13,276  
View All

Units:

Millions of Dollars,
Not Seasonally Adjusted

Frequency:

Quarterly

NOTES

Source: U.S. Census Bureau  

Release: Quarterly Financial Report  

Units:  Millions of Dollars, Not Seasonally Adjusted

Frequency:  Quarterly

Notes:

Further information related to the Quarterly Financial Report survey can be found at https://www.census.gov/econ/qfr/about.html
Methodology details can be found at https://www.census.gov/econ/qfr/documents/QFR_Methodology.pdf

Suggested Citation:

U.S. Census Bureau, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Cash Dividends Charged to Retained Earnings This Quarter [QFR120385USNO], retrieved from FRED, Federal Reserve Bank of St. Louis; https://fred.stlouisfed.org/series/QFR120385USNO, June 23, 2024.

RELATED DATA AND CONTENT

Data Suggestions Based On Your Search

Content Suggestions

Related Categories

Releases

Tags


Subscribe to the FRED newsletter


Follow us

Back to Top
Top